We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




AI Tool Provides Health Advice On Par with Clinicians

By HospiMedica International staff writers
Posted on 04 Jul 2018
A series of tests carried out on an artificial intelligence (AI) tool has demonstrated its ability to provide heath advice, which is on par with practicing clinicians. More...
The AI tool has been developed by Babylon Health (London, UK), which uses a combination of cutting-edge technology and the best available medical expertise to deliver 24-hours-a-day, 7-days-a-week access to digital health tools (including health assessment, triage and health tools), to people across the world.

The AI technology was tested (including the relevant sections of the MRCGP exam) in a transatlantic collaboration between Babylon and the Royal College of Physicians, Stanford Primary Care and Yale New Haven Health. The MRCGP exam is the final test for trainee General Practitioners (GPs), set by the Royal College of General Practitioners (RCGP). Trainee GPs who pass this assessment have demonstrated their competence and clinical skills to a level that is sufficiently high enough for them to undertake independent practice. A key part of this exam tests a doctor's ability to diagnose.

Babylon took a representative sample-set of questions testing diagnostic skills from publicly available RCGP sources, as well as independently published examination preparation materials, and mapped these to the current RCGP curriculum in order to ensure the questions resembled actual MRCGP questions as closely as possible. The average pass mark over the past five years for real-life doctors was 72%, while Babylon's AI scored 81% in sitting the exam for the first time.

Babylon next collaborated with the Royal College of Physicians, Stanford Primary Care and Yale New Haven Health to further test the AI's capabilities alongside seven highly experienced primary care doctors using 100 independently-devised symptom sets (or 'vignettes'). Babylon's AI scored 80% for accuracy, while the seven doctors achieved an accuracy range of 64-94%. The accuracy of the AI was 98% when assessed against conditions seen most frequently in primary care medicine. In comparison, when Babylon's research team assessed experienced clinicians using the same measure, their accuracy ranged from 52-99%. More importantly, the safety of the AI was 97%, which compares favorably to the average of 93.1% for the doctors.

As the AI is continues to learn and accumulate knowledge, Babylon expects subsequent testing to produce significant improvements in terms of results. Babylon's technology provides health information, rather than a medical diagnosis, for regulatory reasons. The tests carried out relate to the diagnostic exams taken by doctors as a benchmark for accuracy, however, Babylon's AI service remains an information service, rather than a medical diagnosis.

“The World Health Organization estimates that there is a shortage of over 5 million doctors globally, leaving more than half the world's population without access to even the most basic healthcare services. Even in the richest nations, primary care is becoming increasingly unaffordable and inconvenient, often with waiting times that make it not readily accessible. Babylon's latest AI capabilities show that it is possible for anyone, irrespective of their geography, wealth or circumstances, to have free access to health advice that is on-par with top-rated practicing clinicians,” said Dr. Ali Parsa, Babylon's Founder and CEO. “Tonight's results clearly illustrate how AI-augmented health services can reduce the burden on healthcare systems around the world. Our mission is to put accessible and affordable health services into the hands of every person on Earth. These landmark results take humanity a significant step closer to achieving a world where no-one is denied safe and accurate health advice.”

Related Links:
Babylon Health


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Leg Wraps
Leg Wraps
New
Enteral Feeding Pump
Instilar 1420
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The Minder Implant can record brain activity continuously for very long periods (Photo courtesy of Epiminder)

Implantable Device Continuously Monitors Brain Activity in Epileptic Patients

Epilepsy is one of the most prevalent and serious chronic neurological disorders, impacting around 52 million people globally. It is characterized by recurrent seizures, which are caused by abnormal electrical... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.